Research Questions:
1. What is the association between primary and second primary cancers and the development of cognitive diseases?
2. How do inflammatory diseases influence patient survival among cancer patients?
3. What are the combined effects of cancer, cognitive decline, and inflammation on patient outcomes?
4. How can we detect early cancer based on the metabolites, biomarkers, sequencing data, and clinical imaging?
Aims:
1. To analyze the relationship between different cancer types and the incidence of cognitive and inflammatory diseases.
2. To evaluate the impact of cognitive and inflammatory conditions on the survival rates of cancer patients.
3. To identify potential biomarkers that could predict patient outcomes or detect early cancers.
